0 items USD 0.00Search
Your search for "global markets direct vascular endothelial growth factor b vegf related factor vegfb pipeline 0" gave back 84109 results.
The global Anti-angiogenic Ophthalmic Agent market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Angiogenesis Therapeutic Agent market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Anti-angiogenic Ophthalmic Agent market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global Angiogenesis Therapeutic Agent market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Summary Publisher estimates that the Vascular Endothelial Growth Factor market size will grow from xxx Million USD in 2020 to xxxx Million USD by...
Catalog:
HYR
April 2021
Price: USD 2,000.00
Summary The Vascular Endothelial Growth Factor market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx...
Catalog:
HYR
March 2021
Price: USD 2,000.00
The global Bevacizumab Monoclonal Antibody Biosimilar market size was valued at USD 1379.8 million in 2022 and is forecast to a readjusted size of...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Bevacizumab Monoclonal Antibody Biosimilar market size is expected to reach $ 484.9 million by 2029, rising at a market growth of -13.9%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Macular Edema and Macular Degeneration are two distinct eye conditions that affect the macula, a small but crucial part of the retina responsible for...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Summary HeyReport estimates that the Tyrosine Kinase Inhibitors market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Stromal Vascular Fraction (SVF) Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected...
Catalog:
LPI
November 2023
Price: USD 3,660.00
The global Stromal Vascular Fraction (SVF) Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
November 2023
Price: USD 4,480.00
